Shiseido offsets stagnant domestic sales

By Simon Pitman

- Last updated on GMT

Related tags Sales Revenue

Strong sales growth in Asia and Europe have helped to offset
falling sales in the domestic Japanese market, says global
cosmetics player Shiseido.

The company reported that in the nine months up to December 31, 2007, sales grew by 3.7 per cent to ¥536.73bn (€3.4bn), compared to the same period in 2006 when sales grew by 3.4 per cent to ¥517.33bn. Strong sales growth in Asia and Europe have helped to offset falling sales in the domestic Japanese market, says global cosmetics player Shiseido. The company also reported a big rise in its operating income for the nine month period on the back of cost savings, rising 23.3 per cent to ¥50.25bn, compared to the same period last year. The company stated that the cost savings were derived from the result of marginal gains from its overseas expansion, an improved cost of sales ratio and a decline in domestic marketing expenses. Net profits up nearly 30 per cent​ The strong rise in the operating profit, combined with the more modest rise in group sales helped to push net income up by 29.3 percent to ¥26.21bn for the nine month period, a figure that was boosted by gains from the sale of shares in a logistics subsidiary, as well as a weak yen. Breaking the sales figure for the period down on a geographical basis, the company's core domestic market continues to present challenging conditions. Total sales for the period in Japan were ¥366.51, a fall of 2 per cent compared to the ¥374.0bn recorded a year earlier - a figure that reflected stiff competition and a price-sensitive retail environment. In Europe, the company's second largest market, sales grew by 21 per cent for the period, up from ¥67.38bn a year earlier to reach ¥81.40bn - a figure that was attributed to the the strength of the Shiseido brand and designer fragrances. Biggest gains come from China​ However, the biggest gains were seen in the Asia and Oceania market, where sales grew by 21.4 per cent, up from ¥58.29bn a year earlier, to reach ¥70.76bn for the nine month period ending in December. The company said that the highlight in the Asia and Oceania market had been China, where dedicated brands specifically aimed at Chinese consumers had performed 'outstandingly'. In the US sales grew by 11.1 per cent to reach ¥48.65bn, gains that, as in Europe, were attributed to the strength of the Shiseido brand and designer fragrances. On the back of the poorer performance in the domestic market, Shiseido has cut its full financial year sales forecast from ¥730bn to ¥ 725bn, but said that projections for full year profits would remain the same, at ¥60bn.

Related news

Show more

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast